Article
Clonal hematopoiesis and VEXAS syndrome: survival of the fittest clones?
Seminars in hematology - 1 Oct 2021
Kusne Yael, Fernandez Jenna, Patnaik Mrinal M
Abstract excerpt
Clonal hematopoiesis (CH) is defined by the acquisition of somatic mutations in hematopoietic stem cells (HSC) leading to enhanced cellular fitness and proliferation under positive clonal selection pressures. CH most frequently involves epigenetic regulator genes (DNMT3A, TET2 and ASXL1), with these mutations being associated with enhanced inflammation and increased all-cause mortality largely from cardiovascular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
